Rio Tinto Posts Strong Q4 Iron Ore and Copper Output on Operational Recovery 
U.S. Vaccine Policy Shifts Under RFK Jr. Create Uncertainty for Pharma and Investors 
Valentino Garavani Dies at 93, Leaving Behind the Timeless Legacy of Valentino Red 
Valero Makes First Venezuelan Crude Purchase Under New U.S.-Caracas Deal 
Lynas Rare Earths Shares Surge as Quarterly Revenue Jumps on Strong Prices 
BHP Posts Record Iron Ore Output as China Pricing Pressures Loom 
Morgan Stanley Flags High Volatility Ahead for Tesla Stock on Robotaxi and AI Updates 
Court Allows Expert Testimony Linking Johnson & Johnson Talc Products to Ovarian Cancer 
Pop Mart Shares Surge in Hong Kong After First Buyback in Nearly Two Years 
SoftBank Shares Surge as AI Optimism Lifts Asian Tech Stocks 
Memory Chip Shortage Drives Higher Gadget Prices and Weakens Global Tech Demand 
Apple China Holiday Sale Offers Discounts Up to 1,000 Yuan on Popular Devices 
JPMorgan and Allen & Company Emerge as Big Winners in Warner Bros Discovery Bidding War 
FAA Says It Is Not Blocking Boeing 737 MAX 7 and MAX 10 Certification 
OpenAI Launches Stargate Community Plan to Offset Energy Costs and Support Local Power Infrastructure 
Trump Signs Executive Order to Limit Wall Street Investment in Single-Family Homes 
Walmart to Cut PhonePe Stake in IPO as Tiger Global and Microsoft Exit 
NEW YORK, May 02, 2017 -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the Northern District of California on behalf of investors who purchased Amyris, Inc. ("Amyris") (NASDAQ:AMRS) securities between March 2, 2017 and April 17, 2017.
Click here to learn about the case: http://www.wongesq.com/pslra-sa/amyris-inc?wire=3. There is no cost or obligation to you.
According to the complaint, throughout the Class Period, the Company issued materially false and misleading statements and/or failed to disclose that: (1) in the first quarter of 2017, Amyris made a decision to take an equity stake in one of Blue California’s affiliates that focused on the sweetener market in lieu of cash payment under the license agreement; (2) consequently, due to Amyris’ decision, Amyris would be unable to recognize $10 million in fourth quarter and fiscal year 2016 revenue from the license agreement with Blue California; and (3) as a result, defendants’ public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.
If you suffered a loss in Amyris you have until June 19, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. To obtain additional information, contact Vincent Wong, Esq. either via email [email protected], by telephone at 212.425.1140, or visit http://www.wongesq.com/pslra-sa/amyris-inc?wire=3.
Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Vincent Wong, Esq. 39 East Broadway Suite 304 New York, NY 10002 Tel. 212.425.1140 Fax. 866.699.3880 E-Mail: [email protected]
